A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood
Clinical trial NCT07774325 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07774325
- Sponsor
- Boehringer Ingelheim
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2026-10-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.